Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway-Reference-Cited by-同舟云学术

Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway

Published:2017-12 Issue: Volume:96 Page:619-625
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Jiang Jin,Yuan Zuguo,Sun Yiqing,Bu Yuan,Li Wenfeng,Fei Zhenghua

Funder

Natural Science Foundation of Zhejiang

Wenzhou Science and Technology Bureau Foundation

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference38 articles.

1. Prevention of pancreatic cancer;Kuroczycki-Saniutycz;Contemp. Oncol. (Pozn.),2017

2. Treatment options for advanced pancreatic cancer: a review;Warsame;Expert Rev. Anticancer Ther.,2012

3. Epidermal growth factor receptor expression in human pancreatic cancer: significance for liver metastasis;Tobita;Int. J. Mol. Med.,2003

4. Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysis;Furuse;Jpn. J. Clin. Oncol.,2017

5. Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib;Banno;Int. J. Oncol.,2017

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1α/VEGF;Toxicology and Applied Pharmacology;2024-05

2. Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications;Current Topics in Medicinal Chemistry;2024-04

3. Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight;Phytotherapy Research;2024-03-03

4. The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR;Journal of Ethnopharmacology;2024-01

5. Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma;Cell Communication and Signaling;2023-12-18